The Robert Wood Johnson Foundation (RWJF) recently recognized Public Health Accreditation Board (PHAB) Board Member F. Douglas Scutchfield, MD, for "bringing new visibility and credibility to the field during a time of rapid change in public health and health care" in the United States.
Epidemiologists examine public health problems through a wide-scope lens to determine the impact of disease and health disparities at the population-level. Medical practitioners, on the other hand, are attuned to the health problems of the individual.
During the spring 2016 semester, students in Dr. Henrietta Bada’s maternal and child health course discovered both perspectives are helpful — and necessary — for solving the health problems impacting children and mothers in Kentucky.
Three of the college’s outstanding faculty received teaching awards presented at the graduation reception on May 6, 2016. These awards recognize faculty achievement in teaching and mentoring.
Close to half of patients with severe or difficult to treat asthma participating in a large trial still had poorly controlled symptoms after a decade, researchers reported here.
The multicenter, observational TENOR II study evaluated the prevalence of persistent very poorly controlled asthma more than 10 years after their enrollment in TENOR I, which was designed to examine the causes of poor asthma control in this subset of patients.
Welcome to the era of precision medicine — a new frontier in health care delivery with the promise of improving outcomes and extending lives.
Precision medicine is an individualized approach to achieving optimal health founded on the premise that our DNA, our environments and our lifestyle choices are the three major predictors of our health. The goal of precision medicine is to improve the efficacy of modern health care delivery by integrating these three factors as part of disease prevention and treatment. Personalized medicine, a related concept, refers to examining the signs, symptoms, evidence, and patient experience and preferences to guide medical decision-making.
A new study led by University of Kentucky researchers and published in Nature shows a potential new biological marker for the development of obesity and a possible target for obesity prevention and treatment.
Neurotensin (NT), a peptide produced mainly in the gastrointestinal tract and central nervous system, is released with fat ingestion and facilitates fatty acid absorption in the intestine. Previous research has shown that NT can also stimulate the growth of various cancers and increased fasting levels of pro-NT (an NT precursor hormone) are associated with development of cardiovascular disease and breast cancer.
The University of Kentucky Board of Trustees today approved 17 University Research Professorships for the 2016-17 year.
The US is generally prepared to manage public health emergencies like the Houston floods, a Zika virus outbreak or a potential bioterrorist attack, but health protections aren’t distributed evenly across the country, according to a new state-by-state analysis.
The 2016 National Health Security Preparedness Index, which measures how communities respond to and recover from “large-scale emergencies,” shows states getting better in areas like health security and engaging their communities than 2014 and 2015. But the national index score of 6.7 on a 10-point scale shows plenty of room for improvement.
Donna Arnett, dean of the University of Kentucky College of Public Health, outlined implications for researchers as the nation’s health care system pivots toward precision medicine during the Center for Clinical and Translational Sciences (CCTS) 11th annual conference on April 21, 2016.
University of Kentucky's Larry Goldstein MD and Donna Arnett, Ph.D., took part in drafting a policy statement that was published in the American Heart Association’s (AHA) flagship journal Circulation this month.
The statement was intended to provide a thorough review of the scientific underpinnings of the AHA’s public advocacy strategies as they pertain to the association's 2020 Strategic Impact Goals, which target a 10-year 20 percent improvement in the cardiovascular health of all Americans and a 20 percent reduction in deaths from cardiovascular disease and stroke.